gip/glp-1 tirzepatide GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 Unveiling Tirzepatide's Therapeutic Spectrum: A
Description
For a comprehensive side effect overview, see our tirzepatide side effects guide
Both receptors exist in brain regions that regulate appetite, and their combined activation produces stronger appetite suppression than targeting either receptor alone
These include those that impede insulin regulation or increase hunger sensations counteracting the medication's effects
or very rapid heartbeat.Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported
